Search results
AstraZeneca admits its Covid vaccine can cause rare side effect in court documents for first time
The Telegraph via Yahoo News· 3 days agoAstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause a...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 6 days agoA major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the...
AstraZeneca admits Covishield jab raises TTS risk. Should you be worried?
Investing.com· 1 day agoNew Delhi, April 30 (IANS) Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is...
Pfizer profits drop on lower Covid-19 product sales
Digital Journal· 3 hours agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
Pfizer lifts profit view on cost cuts, higher COVID vaccine demand
Reuters· 4 hours ago, opens new tab lifted its annual profit forecast, banking on cost cuts, a smaller-than-feared drop...
Vax benefits outweigh risks of extremely rare potential side effects: AstraZeneca
Investing.com· 1 day agoNew Delhi, April 30 (IANS) Benefits of the Covid-19 vaccine far outweigh the risks of extremely rare...
Nonprofit group Louisiana Families for Vaccines voice concerns over proposed bills
WBRZ 2 Baton Rouge· 4 hours agoThe nonprofit group Louisiana Families for Vaccines is hoping six of the 13 proposed bills about COVID and vaccines will not become law ...
Pfizer lifts 2024 profit view on cost cuts, higher COVID vaccine demand
WHTC 1450 Holland· 5 hours ago(Reuters) -Pfizer lifted its annual profit forecast on Wednesday, banking on cost cuts and...
AstraZeneca cops to rare, deadly side effect of COVID jab as lawsuits mount
New York Post· 2 days agoAstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood-clotting...
Man behind China’s first approved Covid-19 shot loses seat in legislature
South China Morning Post· 3 days agoThe NPC statement, which followed a four-day meeting of its standing committee, suggests Yang is...